Hannover, Germany, December 03, 2018 / B3C newswire / -- Ophthalmic medical device company Implandata Ophthalmic Products GmbH (Implandata) announced today that the f...

Patients with hereditary angioedema experience recurrent and sometimes life-threatening swelling attacks. Researchers from Charité - Universitätsmedizin Berlin have t...

The U.S. Food and Drug Administration approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the...

Confirmed clean safety profile No serious or severe adverse effects Primary endpoints of safety and pharmacokinetic data achieved Stevenage, UK, November 26, ...

Basel, Switzerland, November 28th, 2018. Clinerion upgrades its website with realtime statistics from Patient Network Explorer and a dynamic map searchable for diseas...

Spinraza®▼(nusinersen) yet to be made available by NHS England following NICE interim rejection Maidenhead, UK. – 16 November, 2018 – Biogen was announced as the winn...

Health research is thriving in the UK with more people taking part in NHS clinical research than ever before, new figures from the National Institute for Health Resea...